Jaroline Pharma SRL
Jaroline Pharma reported total assets of 584,142 € at the end of the 2025 financial year (annual accounts filed with the NBB on 24 Jul 2026).
The score of Jaroline Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Jaroline Pharma's annual accounts
| 2025 | |
|---|---|
| Net result | −1,387 € |
| Equity | 3,613 € |
| Cash | 4,036 € |
| Total assets | 584,142 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 24 Jul 2026
Jaroline Pharma's financial analysis
- Solvency0.6%sector median: 46.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Jaroline Pharma
Jaroline Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1023.796.101
- VAT number
- BE1023796101
- Peppol
- Registered · 0208:1023796101 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 28 May 2025
- Registered office
- 5070 Fosses-la-Ville
- Latest accounts
- 2025 · filed on 24 Jul 2026
- Activity
- Activities of holding companies (NACE 64210)
Jaroline Pharma (SRL) has been based in Fosses-la-Ville since 2025, active in: activities of holding companies. For 2025, it reports a net loss of 1,387 € and equity of 3,613 €; its revenue is not published. Its solvency stands at 0.6%, below the median of its sector (46.9%).
Companies similar to Jaroline Pharma
Companies in the same business, of comparable size and area, outside its group.
- Donckers Management Activities of holding companies Brasschaat · balance sheet 582,740 €
- Dsmt² Activities of holding companies Ghent · balance sheet 580,130 €
- Flux Consulting Activities of holding companies Heusden-Zolder · balance sheet 588,821 €
- Devax Activities of holding companies Sint-Martens-Latem · balance sheet 572,893 €
- 1D Sheep Collective Activities of holding companies Lubbeek · balance sheet 572,807 €
- Javico Activities of holding companies Kruisem · balance sheet 572,683 €
- Caserne Holdings Activities of holding companies Zaventem · balance sheet 596,758 €
- NOMAS consultancy Activities of holding companies Antwerp · balance sheet 564,573 €
Frequently asked questions about Jaroline Pharma
What is the revenue of Jaroline Pharma?
Jaroline Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Jaroline Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE1023796101 for Jaroline Pharma, if the company is VAT-registered. Its company number (CBE) is 1023.796.101.
Where is the registered office of Jaroline Pharma?
According to the CBE register, the registered office of Jaroline Pharma is in 5070 Fosses-la-Ville.
What is the equity of Jaroline Pharma?
At the close of the 2025 financial year, the equity of Jaroline Pharma amounts to 3,613 €, a solvency of 0.6% of total assets.
Who manages Jaroline Pharma?
The register lists 1 active mandates at Jaroline Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Jaroline Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →